February 23, 2017
Abivax discovers molecules active against dengue fever
Abivax, a biotechnology company targeting the immune system to eliminate viral diseases, has recently discovered several molecules that are active against the virus in vitro, some of which could be developed as therapeutic drug-candidates against dengue fever.